Atlas Trials

First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

Clinical trial NCT05374278 · RECRUITING

Trial details

NCT number
NCT05374278
Sponsor
David Wilson
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer DiseaseFrontotemporal DementiaDementia
Start date
2021-11-02
Primary completion
2027-04-03
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.